2026 Fall CTSA Program Annual Meeting

Meeting materials will be found within the agenda once they become available.

September 22 | Steering Committee Meeting

September 23 | EC Plenary Session, Administrative and Leadership Meetings: Trial Innovation Network, Hub Administrators, Enterprise Committees (BIDS, Collaboration & Engagement, Integration Across the Lifespan, Workforce Development)

September 24-25 | General Session Presentations | Poster Presentations | UPI Meeting

Keynote Address by Karim Mikhail, Acting Director of the FDA’s Center for Biologics Evaluation and Research (CBER). Session topics include: AI use cases in real-world research, innovative trial designs, research expansion into rural areas, workforce development and research staff career pathways and scaling recruitment services and infrastructure.

Location:

Marriott Marquis Washington DC

901 Massachusetts Ave, NW, 

Washington, DC 20001

Reservations:

Marriott Reservations - 2026 Fall CTSA Program Annual Meeting

CCOS has reserved a limited block of rooms for this meeting. All reservations are on a first-come, first-serve basis and must be booked through the housing link. The room block closes on August 31, 2026.

Each hub may send up to 9 attendees, not including not including TIN Meeting Participants, General Session Speakers, Poster Presenters, Steering Committee, or Fall Planning Committee members. This includes:

• Up to 5 representatives of hub leadership (per the NOFO)
• 1 representative per EC (up to 4 total)

Registration will open no later than July 30 for Administrative and Leadership meetings, as well as the general sessions. Registration for the Hub Administrators and Trial Innovation Network (TIN) meetings will be managed separately, and information will be provided for those meetings.

Justification for Attendance

Due to the addition of Enterprise Committee meetings to this year’s event, we are planning for a larger number of attendees at both the EC meetings and the general meeting. We strongly encourage Enterprise Committee (EC) members to attend the general sessions along with your hub leadership. Their participation ensures committee perspectives are integrated into broader programmatic discussions and helps align efforts across the CTSA Program. This cross-functional engagement is vital for fostering collaboration and innovation.

Each hub may submit one poster, highlighting a project related to the theme of the Poster Session, “20 Years of CTSA Impact - Past, Present, and Future”. Posters must align with one of the Translational Science Benefits Model (TSBM) domains:

• Clinical and Medical Contributions
• Community and Public Health
• Economic Benefits
• Policy*

* Hubs submitting to this category must clearly indicate that research was what the CTSA grant supported and NOT any advocacy or legislative influence activities. Per the NIH Grants Policy statement, hubs should pay special attention to reporting/describing activities focused on reporting Policy and Legislative Impacts under the TSBM model or any aspect of a NIH funded CTSA grant. However, no grant funds including personnel costs may be used for activities.

UL1/UM1 Principal Investigators are requested to work with their respective teams to select a hub initiative that exemplifies impact on Translational Science.

Traditional scientific research posters are not the focus of this year’s program. This is not a juried poster session. Instead, this year’s poster session focuses on showcasing demonstrable impact in translational science and highlighting the contributions of CTSAs.